(Q39009648)

English

IDO is highly expressed in breast cancer and breast cancer-derived circulating microvesicles and associated to aggressive types of tumors by in silico analysis

scientific article published on April 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

8 September 2017

IDO is highly expressed in breast cancer and breast cancer-derived circulating microvesicles and associated to aggressive types of tumors by in silico analysis (English)

1 reference

Europe PubMed Central

8 September 2017

1 reference

based on heuristic

inferred from title

Amada Segal-Eiras

6

object named as

A Segal-Eiras

1 reference

Europe PubMed Central

8 September 2017

Martín Enrique Rabassa

2

object named as

M E Rabassa

1 reference

Europe PubMed Central

8 September 2017

María Virginia Croce

7

object named as

M V Croce

1 reference

Europe PubMed Central

8 September 2017

Marina Teresita Isla Larrain

1

object named as

M T Isla Larrain

1 reference

Europe PubMed Central

8 September 2017

author name string

E Lacunza

3

1 reference

Europe PubMed Central

8 September 2017

A Barbera

4

1 reference

Europe PubMed Central

8 September 2017

A Cretón

5

1 reference

Europe PubMed Central

8 September 2017

publication date

1 April 2014

1 reference

Europe PubMed Central

8 September 2017

1 reference

Europe PubMed Central

8 September 2017

35

1 reference

Europe PubMed Central

8 September 2017

7

1 reference

Europe PubMed Central

8 September 2017

6511-6519

1 reference

Europe PubMed Central

8 September 2017

https://scigraph.springernature.com/pub.10.1007/s13277-014-1859-3

0 references

Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1859-3

21 January 2018

Inhibition of T cell proliferation by macrophage tryptophan catabolism

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1859-3

21 January 2018

Indoleamine 2,3-dioxygenase and tumor-induced tolerance

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1859-3

21 January 2018

Inducing the tryptophan catabolic pathway, indoleamine 2,3-dioxygenase (IDO), for suppression of graft-versus-host disease (GVHD) lethality

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1859-3

21 January 2018

Indoleamine 2,3 dioxygenase and metabolic control of immune responses

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1859-3

21 January 2018

Studying the immunosuppressive role of indoleamine 2,3-dioxygenase: tryptophan metabolites suppress rat allogeneic T-cell responses in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1859-3

21 January 2018

Interplay of natural killer cells and their receptors with the adaptive immune response

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1859-3

21 January 2018

L-kynurenine-induced apoptosis in human NK cells is mediated by reactive oxygen species

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1859-3

21 January 2018

Tumour-derived exosomes or microvesicles: another mechanism of tumour escape from the host immune system?

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1859-3

21 January 2018

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1859-3

21 January 2018

TNBCtype: A Subtyping Tool for Triple-Negative Breast Cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1859-3

21 January 2018

A gene expression signature identifies two prognostic subgroups of basal breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1859-3

21 January 2018

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1859-3

21 January 2018

High expression of indoleamine 2,3-dioxygenase in the tumour is associated with medullary features and favourable outcome in basal-like breast carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1859-3

21 January 2018

Analysis of indoleamine 2-3 dioxygenase (IDO1) expression in breast cancer tissue by immunohistochemistry

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1859-3

21 January 2018

Immune modulation of T-cell and NK (natural killer) cell activities by TEXs (tumour-derived exosomes)

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1859-3

21 January 2018

Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism

1 reference

https://pubmed.ncbi.nlm.nih.gov/24687552

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Upregulated expression of indoleamine 2, 3-dioxygenase in primary breast cancer correlates with increase of infiltrated regulatory T cells in situ and lymph node metastasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24687552

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preferential apoptosis of CD56dim natural killer cell subset in patients with cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24687552

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Blocking IDO activity to enhance anti-tumor immunity.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24687552

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumour-derived exosomes and their role in cancer-associated T-cell signalling defects

1 reference

https://pubmed.ncbi.nlm.nih.gov/24687552

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interaction of indoleamine-2,3-dioxyagnase and CD4+CD25+ regulatory T cells in tumor immune escape

1 reference

https://pubmed.ncbi.nlm.nih.gov/24687552

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tissue and Serum MUC1 Mucin Detection in Breast Cancer Patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/24687552

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S13277-014-1859-3

1 reference

Europe PubMed Central

8 September 2017

release_vtqfoa4otjcupk2aphqnsji6ci

1 reference

https://api.fatcat.wiki/v0/release/vtqfoa4otjcupk2aphqnsji6ci

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

8 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39009648&oldid=1837709932"